PM Anderson

400 total citations
13 papers, 339 citations indexed

About

PM Anderson is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, PM Anderson has authored 13 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 3 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in PM Anderson's work include Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (5 papers) and Immunotherapy and Immune Responses (5 papers). PM Anderson is often cited by papers focused on Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (5 papers) and Immunotherapy and Immune Responses (5 papers). PM Anderson collaborates with scholars based in United States. PM Anderson's co-authors include Carmeline O’Brien, Michael A. Caligiuri, Thomas Manley, Jerome Ritz, S F Schlossman, F H Bach, Bruce R. Blazar, Diane E. Hasz, BR Blazar and Jan Watterson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

PM Anderson

13 papers receiving 335 citations

Peers

Countries citing papers authored by PM Anderson

Since Specialization

Citations

This map shows the geographic impact of PM Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PM Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PM Anderson more than expected).

Fields of papers citing papers by PM Anderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by PM Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PM Anderson. The network helps show where PM Anderson may publish in the future.

Co-authorship network of co-authors of PM Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of PM Anderson. A scholar is included among the top collaborators of PM Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with PM Anderson. PM Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Wilms' tumor and neuroblastoma 2004 ·Acta Paediatrica ·(unknown), (unknown), Vilmarie Rodriguez, PM Anderson	12
2	Tell the children. Commentary 2000 ·Journal of Clinical Oncology ·Joanne M. Hilden, Jan Watterson, (unknown), PM Anderson	17
3	Dependency on intercellular adhesion molecule recognition and local interleukin-2 provision in generation of an in vivo CD8+ T-cell immune response to murine myeloid leukemia 1995 ·Blood ·(unknown), (unknown), (unknown), PM Anderson, (unknown), BR Blazar	35
4	Infection of human natural killer (NK) cells with replication-defective human T cell leukemia virus type I provirus. Increased proliferative capacity and prolonged survival of functionally competent NK cells 1992 ·The Journal of Immunology ·K M Lo, Éric Vivier, Nathalie Rochet, (unknown), H Levine, W A Haseltine, PM Anderson	14
5	G19.4(alpha CD3) x B43(alpha CD19) monoclonal antibody heteroconjugate triggers CD19 antigen-specific lysis of t(4;11) acute lymphoblastic leukemia cells by activated CD3 antigen-positive cytotoxic T cells 1992 ·Blood ·PM Anderson, (unknown), Diane E. Hasz, (unknown), Damian E. Myers, Fatih M. Uckun	1
6	Anti-CD3 + interleukin-2 stimulation of marrow and blood: comparison of proliferation and cytotoxicity 1992 ·Blood ·PM Anderson, (unknown), NK Ramsay, Diane E. Hasz, Daniel Weisdorf	11
7	G19.4(alpha CD3) x B43(alpha CD19) monoclonal antibody heteroconjugate triggers CD19 antigen-specific lysis of t(4;11) acute lymphoblastic leukemia cells by activated CD3 antigen-positive cytotoxic T cells 1992 ·Blood ·PM Anderson, (unknown), Diane E. Hasz, (unknown), Damian E. Myers, Fatih M. Uckun	24
8	Proliferation and cytolytic function of anti-CD3 + interleukin-2 stimulated peripheral blood mononuclear cells following bone marrow transplantation 1991 ·Blood ·(unknown), PM Anderson, A. H. Filipovich, (unknown), (unknown), (unknown), (unknown), DJ Weisdorf	2
9	Proliferation and cytolytic function of anti-CD3 + interleukin-2 stimulated peripheral blood mononuclear cells following bone marrow transplantation 1991 ·Blood ·(unknown), PM Anderson, A. H. Filipovich, (unknown), (unknown), (unknown), (unknown), DJ Weisdorf	18
10	Differential regulation of Ca2+ mobilization in human thymocytes by coaggregation of surface molecules. 1990 ·The Journal of Immunology ·K Deusch, J F Daley, Herbert Levine, (unknown), PM Anderson, Stuart F. Schlossman, M L Blue	13
11	Fc gamma receptor type III (CD16) is included in the zeta NK receptor complex expressed by human natural killer cells. 1990 ·Proceedings of the National Academy of Sciences ·PM Anderson, Michael A. Caligiuri, Carmeline O’Brien, Thomas Manley, Jerome Ritz, S F Schlossman	140
12	Anti-CD3+IL-2-stimulated murine killer cells 1989 ·The Journal of Immunology ·PM Anderson, BR Blazar, Bach Fh, (unknown)	5
13	Anti-CD3 + IL-2-stimulated murine killer cells. In vitro generation and in vivo antitumor activity. 1989 ·The Journal of Immunology ·PM Anderson, Bruce R. Blazar, F H Bach, (unknown)	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact